Advertisement
Canada markets open in 6 hours 2 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7271
    +0.0007 (+0.10%)
     

  • CRUDE OIL

    83.70
    +0.97 (+1.17%)
     

  • Bitcoin CAD

    88,844.99
    +4,546.89 (+5.39%)
     

  • CMC Crypto 200

    1,334.53
    +21.90 (+1.67%)
     

  • GOLD FUTURES

    2,404.80
    +6.80 (+0.28%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,442.50
    -104.75 (-0.60%)
     

  • VOLATILITY

    18.00
    0.00 (0.00%)
     

  • FTSE

    7,844.90
    -32.15 (-0.41%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Stereotaxis to Report Third Quarter Financial Results on November 10, 2022

Stereotaxis, Inc.
·2 min read
Stereotaxis, Inc.
Stereotaxis, Inc.

ST. LOUIS, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2022 third quarter on Thursday, November 10, 2022 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments.

What:

Stereotaxis third quarter 2022 financial results conference call

 

 

When:

Thursday, November 10, 2022, at 10:00 a.m. EST (7:00 a.m. PST)

 

 

Dial In Number:

To access the live call, dial 800-715-9871 (US and Canada) or 1-646-307-1963 (International) and give the participant pass code 5729833.

 

 

Webcast:

To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/.

 

 

Call Replay:

A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here.

 

 

About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.

Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer

Media Contact:
Bethanne Schluter
Director, Marketing & Communications

 

 

Kimberly Peery
Chief Financial Officer

 

 

 

314-678-6100
Investors@Stereotaxis.com